Our mission is to elucidate the determinants of genotype-to-phenotype interplays in hematopoietic neoplasms.
Somatic mutations drive the development of hematopoietic neoplasms. Yet, patients with the same mutations result in distinct clinical disease states and outcomes. We seek to understand why.
Our goal is to build a diverse, collaborative community of {com}passionate scientists - with a strong desire to make fundamental discoveries for translational impact.